MedPath

Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea

Phase 4
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Registration Number
NCT00864812
Lead Sponsor
The Korean Academy of Tuberculosis and Respiratory Diseases
Brief Summary

Study title

* A randomized, open label, multicenter, phase 4 study for the comparison of efficacy of tiotropium plus salmeterol/ fluticasone propionate compared with tiotropium alone in COPD patients

Study objectives

* To investigate clinical outcomes of combining tiotropium with fluticasone propionate/salmeterol (FSC) 250/50μg bid compared with tiotropium alone in patients with moderate or severe COPD in Korea

Study Design

* Randomized, open-label, multicenter, parallel-group, two group study

Study assessment

* FEV1

* Inspiratory capacity (IC)

* History of COPD exacerbation

* History of hospitalization for COPD exacerbation and all causes

* QoL (SGRQ-C)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
509
Inclusion Criteria
  • Subjects Aged 40 to 80 years.
  • Subjects diagnosed with COPD.
  • Tobacco smoking 10 pack-years or more.
  • Subjects with post-bronchodilator FEV1/FVC < 0.7 and FEV1 < 65% predicted.
Exclusion Criteria
  • Subjects with a history of physician-diagnosed asthma or a respiratory disorder other than COPD which is clinically significant such as diffuse bilateral bronchiectasis.
  • Subjects suffering from serious diseases likely to interfere with the study such as chronic congestive heart failure.
  • Subjects who used systemic corticosteroids within 4 weeks prior to study entry.
  • Subjects with any malignant disease.
  • Subjects with a history of severe glaucoma, urinary tract obstruction.
  • Previous lung volume reduction surgery.
  • Subjects who are pregnant or breastfeeding.
  • Subjects with a known hypersensitivity or intolerance to tiotropium or fluticasone-salmeterol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1tiotropium with fluticasone propionate/salmeterol (FSC)tiotropium with fluticasone propionate/salmeterol (FSC)
2tiotropiumtiotropium
Primary Outcome Measures
NameTimeMethod
Changes in pre-dose FEV1 from baseline at 24 weeks after treatment24 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in pre-dose FEV1 from baseline and IC from baseline, COPD exacerbation, QoL and safety24 weeks

Trial Locations

Locations (32)

Kyunghee university medical center

🇰🇷

Seoul, Korea, Republic of

Inje university Pusan Paik hospital

🇰🇷

Busan, Korea, Republic of

Soonchunhyang University Bucheon Hospital

🇰🇷

Bucheon, Korea, Republic of

Chonbuk national university hospital

🇰🇷

Chunbuk, Korea, Republic of

Chungbuk national university hospital

🇰🇷

Chungbuk, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Chungnam, Korea, Republic of

Keimyung university dongsan medical center

🇰🇷

Daegu, Korea, Republic of

Gachon University Gil Hospital

🇰🇷

Inchon, Korea, Republic of

Inha university Hospital

🇰🇷

Inchon, Korea, Republic of

Kyungpook national university hospital

🇰🇷

Daegu, Korea, Republic of

Yeungnam University Hospital

🇰🇷

Daegu, Korea, Republic of

Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

Inje university Seoul Paik Hospital

🇰🇷

Seoul, Korea, Republic of

Kyunghee university east-west neo medical center

🇰🇷

Seoul, Korea, Republic of

Ewha womans university mokdong hospital

🇰🇷

Seoul, Korea, Republic of

Kangdong Scared heart Hospital

🇰🇷

Seoul, Korea, Republic of

Kangnam St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Hanyang University Hospital

🇰🇷

Seoul, Korea, Republic of

Konkuk university hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

Samsung medical center

🇰🇷

Seoul, Korea, Republic of

Uijeongbu St. Mary's Hospital

🇰🇷

Uijeongbu, Korea, Republic of

Ajou university hospital

🇰🇷

Suwon, Korea, Republic of

Wonju Christian Hospital

🇰🇷

Wonju, Korea, Republic of

Hallym University scared heart hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Soonchunhyang University hospital

🇰🇷

Seoul, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

St. Paul's Hospital

🇰🇷

Seoul, Korea, Republic of

Incheon St. Mary's Hospital

🇰🇷

Inchon, Korea, Republic of

Gyeongsang national university hospital

🇰🇷

Jinju, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath